Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Unusual challenges in clinical oncology: YO case discussions

YO21 - A Rare Case of Pancreatic Metastasis from Primary Lung Adenocarcinoma. A Non Surgical Approach


03 Dec 2022


Unusual challenges in clinical oncology: YO case discussions


Targeted Therapy

Tumour Site

Non-Small Cell Lung Cancer


Aqueel Shahid


A. Shahid1, S.M. Raza1, T. Sadaf2

Author affiliations

  • 1 Clinical And Radiation Oncology, Shaukat Khanum Memorial Cancer Hospital and Research Centre, 54770 - Lahore/PK
  • 2 Clinical And Radiation Oncology, SKMCH-RC - Shaukat Khanum Memorial Cancer Hospital and Research Centre, 54550 - Lahore/PK


Login to access the resources on OncologyPRO.

Abstract YO21

Case summary

44 year old male, non-smoker with no comorbidities, presented to us with complains of cough for 6 months and fever for 2 months. His CT scan was done from outside hospital which showed a heterogeneous left lower lobe mass with few adjacent tiny nodules and significant adjacent thickened pleura. He had underwent biopsy of the lesion which revealed poorly differentiated carcinoma with features favoring pleomorphic carcinoma of lung.

His histopathology was reviewed at the hospital and showed Adenocarcinoma Grade III, TTD-1 positive, Synoptophysin Negative. His Staging PET CT scan was done in house which remonstrated a hyper-metabolic left lower lobe lung mass 7.2cm in size with mediastinal and left level IV cervical lymphadenopathy. There was no evidence of FDG avid visceral or osseous metastases. His final staging according to AJCC 8th edition was T4N3M0 disease.

He was discussed in MDT and was recommended to undergo induction chemotherapy for 2 cycles followed by response assessment. Patient was offered 2 cycles of cisplatin 75mg/m2 and Pemetrexed 500mg/m2. His response assessment scan showed partial treatment response. He was then offered concurrent chemo-radiation 55 Gray in 20 fractions with Cisplatin 100mg/m2 on Day 1 and Vinorelbine 50mg/m2 on Day 1 8 and 15. Patient has a near complete response to treatment and remained on follow up with his subsequent scan showing no recurrent disease

After 8 months post treatment he developed pain in right side of abdomen radiating to the back. His CT abdomen was performed which showed a progressive soft tissue mass in para duodenal /peri-pancreatic area inseparable from uncinate part of pancreas. His Endoscopic ultrasound and biopsy of the lesion was done. Histopathology showed Metastatic Adenocarcinoma from primary lesion with EGFR mutated at Exon 21 and ALK rearrangement not detected.

Patient was offered palliative Radiation 20 Gray in 5 fraction for pain control to pancreatic mass and was offered Erlotinib 150mg once daily. There was significant response to treatment clinically and radiologically. Post 6 months there was no residual disease left. Patient remained on follow up till now

Clinical trial identification

Editorial acknowledgement

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.